 |
|
Withdrawal Syndromes and the Cessation of Antihypertensive Therapy
Gary R. Hart, MD;
Ron J. Anderson, MD
Arch Intern Med. 1981;141(9):1125-1127.
Abstract
• A review of the available literature concerning sudden withdrawal of antihypertensive drugs shows that withdrawal syndromes after cessation of such agents have occurred with β-blockers, methyldopa, clonidine hydrochloride, guanabenz, and bethanidine sulfate. Most commonly, these syndromes are limited to nervousness, tachycardia, headache, and nausea 36 to 72 hours after cessation of the drug. In rare cases, serious exacerbation of myocardial ischemia (β-blockers) or hypertension (clonidine, methyldopa) may occur in the posttreatment period. The withdrawal syndromes generally respond promptly to reinstitution of antihypertensive therapy. The infrequent occurrence of withdrawal syndromes should not discourage use of these efficacious agents.
(Arch Intern Med 1981;141:1125-1127)
Author Affiliations
From the Department of Internal Medicine, The University of Texas Health Science Center at Dallas.
Footnotes
Accepted for publication June 9, 1980.
Reprint requests to Department of Internal Medicine, The University of Texas Health Science Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75235 (Dr Hart).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Safe Discontinuation of Antihypertensive Therapy
Kirk and Johnson
Arch Fam Med 1995;4:266-270.
ABSTRACT
The Relative Risk of Incident Coronary Heart Disease Associated With Recently Stopping the Use of {beta}-Blockers
Psaty et al.
JAMA 1990;263:1653-1657.
ABSTRACT
Comparison of Oxprenolol vs Methyldopa as Second-Line Antihypertensive Agents in the Elderly
Traub
Arch Intern Med 1988;148:77-80.
ABSTRACT
|
